Susanne Vetsch
Kardiologie · Dept. I
SWISS TAVI
Nov 4, 2024Prospective, National, Multi-Center Registry of Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) in Switzerland (SwissTAVI)
Register - Nov 4, 2024 - Dec 30, 2040
Ongoing
Members: Haager Philipp, Vetsch Susanne, Maeder Micha
A phase 3 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Amyloid Depleter ALXN2220 in adult participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Oct 1, 2024
Clinical Studies - Oct 1, 2024 - Dec 31, 2029
Scheduled
Project leader: Ehl Niklas
Members: Vetsch Susanne
Pulmonary Vein Isolation with Pulsed-Field Ablation with versus without Posterior wall ablation in Patients with Symptomatic Persistent Atrial Fibrillation
Sep 17, 2024A multicentre randomised clinical trial comparing two ablation strategies for the treatment of persistent AF (PVI only or PVI+ posterior wall ablation). IC: persistent AF, (N)OAK EC: atrial interventions, o. atrium >60mm, TAVI, Ml, >NYHA III, LVEF...
Clinical Studies - Sep 17, 2024 - Sep 17, 2027
Ongoing
Project leader: Franzeck Florian M
Members: Meier Jessica, Vetsch Susanne
Carity Study
Dec 1, 2023CARITY: A targeted approach to ensuring CARe and ActivITY persistence in mid- to older-age persons during and after cardiac rehabilitation following a cardiovascular event or intervention
Clinical Studies - Dec 1, 2023 - Dec 1, 2025
Ongoing
Project leader: Buser Marc
Members: Vetsch Susanne
Vista Study
Oct 23, 2023prospective, observational, global, multicenter study: The objective of the VISTA Study is to evaluate the safety and performance of the Navitor valve in a realworld setting. This study is intended to satisfy post-market clinical follow-up require...
Clinical Studies - Oct 23, 2023 - Oct 30, 2030
Ongoing
Project leader: Haager Philipp K.
Members: Vetsch Susanne
Immunopathological pathways underlying myocarditis and inflammatory cardiomyopathy – an exploratory study
Jul 24, 2023The main hypothesis underlying the suggested research program is that autoimmune CD4+ T cells cross-reacting with bacteria in the intestinal microbiome drive not only the development of acute cardiac inflammation but maintain the perpetuation of infl...
Clinical Studies - Jul 24, 2023 - Jul 24, 2024
Automatically Closed
Project leader: Ludewig Burkhard
Members: Rickli Hans, Maeder Micha, Vetsch Susanne
Oceanic AF
Jun 1, 2023A multicenter, international, randomized, active comparator-controlled, double-blind, doubledummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the preve...
Clinical Studies - Jun 1, 2023 - Jun 30, 2024
Completed
Project leader: Rickli Hans
Members: Fink Karin, Vetsch Susanne
AmplatzerTM PFO Occluder and AmplatzerTM TalismanTM PFO Occluder Post Approval Study
Jun 1, 2023Prospective, single arm, multi-center, international study to confirm the safety and effectiveness of the AmplatzerTM PFO Occluder and AmplatzerTM TalismanTM PFO Occluder in the post approval setting.
Clinical Studies - Jun 1, 2023 - Jun 1, 2028
Ongoing
Project leader: Chronis Joannis
Members: Meier Jessica, Vetsch Susanne
OCEAN
May 1, 2023A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a).
Clinical Studies - May 1, 2023 - Dec 31, 2024
Aborted
Project leader: Bilz Stefan
Members: Räss Andrea, Rickli Hans, Vetsch Susanne
AMGEN202100057
May 1, 2022A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD). The purpose of the study is to characterize the distribution o...
Clinical Studies - May 1, 2022 - Mar 31, 2023
Completed
Project leader: Rickli Hans
Members: Vetsch Susanne, Bilz Stefan, Räss Andrea
SOS AMI Selatogrel
Jan 10, 2022Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjec...
Clinical Studies - Jan 10, 2022 - Jan 14, 2026
Ongoing
Project leader: Maeder Micha
Members: Vetsch Susanne, Fink Karin
SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)
Oct 21, 2021This study is a single armed, prospective, multi-center, observational study Planned: up to 40 study sites in the EU and selected non-EU-countries
Clinical Studies - Oct 21, 2021 - Dec 31, 2026
Ongoing
Project leader: Rigger Johannes
Members: Vetsch Susanne, Fink Karin
CARE-HK in HF Registry
Sep 30, 2021This study is a multinational, multicentre, non-interventional, cohort study of assessment and treatment guideline recommendations in HF patient care in a real-world setting.
Clinical Studies - Sep 30, 2021 - Dec 31, 2025
Completed
Project leader: Maeder Micha
Members: Vetsch Susanne, Schneider Irene
ALFA ROMEO
Jun 23, 2021Atrial fibrillation before and after patent foramen ovale closure study This is a prospective, multicenter, single-arm, observational study assessing the incidence, predictors and prognostic impact of AF occurring before (monitoring phase A) or af...
Clinical Studies - Jun 23, 2021 - Jun 23, 2027
Ongoing
Project leader: Chronis Joannis
Members: Schneider Irene, Vetsch Susanne
CATCH - Cascade genetic testing of familial hypercholesterolemia: the CATCH multicenter randomized controlled trial
Dec 15, 2020To test in a multicenter open-label randomized controlled trial across Switzerland whether a cascade screening programme for FH, in comparison with usual care, will increase the detection rate of FH within families. The primary outcome will be the...
Clinical Studies - Dec 15, 2020 - Mar 31, 2024
Completed
Project leader: Rickli Hans
Members: Vetsch Susanne, Schneider Irene
SILENT 2
Dec 4, 2020Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions Arterial Fibrillation (AF) is well-recognized as a cause for cryptogenic Acute Ischemic Stroke (AIS) and is associated with Silent Brain Infarction...
Clinical Studies - Dec 4, 2020 - Dec 4, 2024
Ongoing
Project leader: Ammann Peter, Kägi Georg
Members: Brenner Roman, Vetsch Susanne, Schneider Irene
PACIFIC AF
Jan 21, 2020Multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group, dose-finding Phase 2 study to compare the safety of the oral FXIa inhibitor BAY 2433334 to apixaban in patients with atrial fibrillation Primary Safet...
Clinical Studies - Jan 21, 2020 - Dec 7, 2021
Completed
Project leader: Rickli Hans
Members: Fink Karin, Vetsch Susanne
AEGIS II_CSL112_3001
Aug 7, 2019A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Clinical Studies - Aug 7, 2019 - Aug 30, 2020
Aborted
Project leader: Rickli Hans
Members: Vetsch Susanne
Flex Nav
Mar 22, 2019This CE Mark study is a prospective, multi-center, single-arm investigational study to support commercialization of the FlexNav™ Delivery System and Loading System in Europe. The design of this clinical investigation is in compliance to ISO standards...
Clinical Studies - Mar 22, 2019 - Mar 30, 2021
Completed
Project leader: Haager Philipp
Members: Vetsch Susanne
Dissecting the association of anti-microbiota antibodies and auto-reactive T-cells in cardiomyopathy– an exploratory research Project
Jan 25, 2018Prospective research project in which biological material is sampled from humans and health-related personal data is collected (HFV Art 6). To generate further scientific evidence for a potential role of crossreactive antimicrobial T and B cell respo...
Clinical Studies - Jan 25, 2018 - Aug 25, 2021
Completed
Project leader: Ludewig Burkhard
Members: Maeder Micha, Vetsch Susanne